Our Company

Our Company Contact Us

       Peptides        Janoshik COA
COA BY Janoshik Ltd. (Independent Analytical Laboratory)

CS-mc10-0120

COA Task Number: 103303
Unique Key: NLVG26FYDJS6
28 JAN 2026
PURITY

99.349%


PEPTIDE CONTENT

12.65 mg


ENDOTOXIN

0.810 EU/vial


HEAVY METALS

Pass(Not Detected)

IDENTITY

Confirmed


MOTS-c 10mg
PRODUCTS

MOTS-c 10mg

View product specifications, research information, and ordering details.
01

Sample Identification
PRODUCT MOTS-c 10mg BATCH CS-mc10-0120
LABORATORY Janoshik Analytical TEST REPORT NOS. #103303 · #105471 · #105465
CLIENT Cocer Peptides MANUFACTURER cocerpeptides.com
VERIFICATION KEYS NLVG26FYDJS6 · IBJQS2KZ73TM · 7HXENFRYJJSM DOCUMENT TYPE Third-Party Laboratory Test Reports
REPORTING PERIOD 28 Jan – 05 Feb 2026  
02

Purity & Quality Analysis

PURITY 99.349%
HPLC Purity / Test Report #103303
PEPTIDE CONTENT 12.65 mg / vial
MOTS-c Content / Test Report #103303
ENDOTOXIN 0.810 EU / vial
Endotoxin Test / Test Report #105465
MOTS-c-10mg
HEAVY METALS
Arsenic (As) —
Not Detected
Cadmium (Cd) —
Not Detected
Lead (Pb) —
Not Detected
Mercury (Hg) —
Not Detected

Heavy Metals Analysis Test Report #105471

Janoshik COA link
03

Testing Methods & COA

CERTIFICATE OF ANALYSIS
1 纯度 #103303
2重金属#105471
内毒素 #105465
PRODUCT IDENTIFICATION

MOTS-c

ANALYSIS SUMMARY
This MOTS-c 10mg batch was independently tested by Janoshik Analytical across three separate test reports. Testing covered peptide content and purity, heavy metals including arsenic, cadmium, lead and mercury, and endotoxin.


The reported results were 12.65 mg/vial peptide content, 99.349% purity, no detected As, Cd, Pb or Hg, and 0.810 EU/vial endotoxin.
PURITY RESULT

99.349%

PEPTIDE CONTENT

12.65 mg / vial

THIRD-PARTY VERIFICATION

Independent third-party testing was completed by Janoshik Analytical for Cocer Peptides batch CS-mc10-0120. The three reports cover peptide content and purity, heavy metals, and endotoxin testing.

TEST REPORT NOS.

REPORTING PERIOD

LAB

BATCH

#103303 · #105471 · #105465

28 Jan – 05 Feb 2026

Janoshik Analytical

CS-mc10-0120

04

Test History for MOTS-c 10 mg

Independent third-party testing history for MOTS-c 10mg.
99.349% Purity

MOTS-c 10mg

Janoshik Analytical · 05 Feb 2026

99.025% Purity

MOTS-c 10mg

Janoshik Analytical · 23 Apr 2026

99.443% Purity

MOTS-c 10mg

Janoshik Analytical · 18 Mar 2026

99.412% Purity

MOTS-c 10mg

Janoshik Analytical · 31 Oct 2025

99.290% Purity

MOTS-c 10mg

Janoshik Analytical · 11 Aug 2025

· MOTS-c 10mg · Batch CS-mc10-0120 · Janoshik Analytical
This laboratory testing information is provided for research reference only. Results apply only to the tested sample(s) associated with the reports shown on this page and may not represent other batches. Products are intended for laboratory research and analytical use only, not for human or veterinary use. Original laboratory reports and verification records should be regarded as the authoritative source.
Cocer Peptides‌™‌ is a source supplier you can always trust.
CONTACT US
  WhatsApp
+852 6904 8891
 
 
  Signal
+852 6904 8891
  Telegram
@CocerService
Telegram Group:
https://t.me/+ritHPUAhhbA0MThh
  Shipping Days
Monday-Saturday /Except Sunday
Orders placed and paid after 12 PM PST are shipped the following business day
Disclaimer: All materials offered by Cocer Peptides are supplied exclusively for legitimate laboratory research, analytical investigation, and in vitro experimental use. They are not offered, labeled, represented, or supplied for human or veterinary administration, consumption, injection, implantation, diagnostic use, therapeutic use, disease prevention, treatment, mitigation, or any other clinical application. Products sold through this website are research materials and are not represented as FDA-approved drug products, medicines, dietary supplements, foods, cosmetics, medical devices, or veterinary products. Cocer Peptides does not provide medical, prescribing, dosing, reconstitution, administration, or clinical-use instructions. Product descriptions, technical information, research articles, references to published scientific literature, and links to third-party materials are provided solely for scientific and educational reference and must not be interpreted as medical advice, treatment recommendations, or evidence of approval for human or animal use. Cocer Peptides does not operate as a pharmacy, does not compound drugs pursuant to patient-specific prescriptions under Section 503A of the Federal Food, Drug, and Cosmetic Act, and is not registered or represented as an outsourcing facility under Section 503B. Purchasers are responsible for ensuring that all materials are acquired, stored, handled, and used only by appropriately qualified personnel in suitable laboratory environments and in accordance with applicable laws, institutional requirements, and safety procedures. As a condition of purchase, the purchaser represents that the materials will not be used in or administered to humans or animals and will not be relabeled, marketed, transferred, or resold for pharmaceutical, therapeutic, diagnostic, clinical, or veterinary purposes. Cocer Peptides reserves the right to refuse, cancel, restrict, or request additional verification for any order where the intended use, purchaser qualifications, destination, or other circumstances are inconsistent with these research-use requirements or applicable law. Additional conditions governing purchase, handling, shipping, liability, and permitted use are set forth in the applicable Terms and Conditions.
Copyright © 2025-2026 Cocer Peptides Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy